Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Johnson & Johnson
- Eli Lilly
累计表现对比（基数100）
每项资产在2025年10月13日时基数为100；数值120表示自该日起上涨20%（最近共同日期：2026年10月9日）。
指标
“不适用”表示该指标对此类资产没有意义：不应进行比较。
| 指标 | Johnson & JohnsonStock | Eli LillyStock |
|---|---|---|
| 业绩与风险 | ||
| Performance over the periodChange in price between the first and last common dates. | +37.0% | +43.9% |
| Annualized performanceAverage annual return that would produce the same total performance. | +37.5% | +44.5% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 19.4% | 34.6% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −11.0% | −23.3% |
| Sharpe RatioReturn achieved above the risk-free rate (5.24%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | 1.80 | 1.39 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −2.0% | −2.7% |
| 基本面 | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 630.04B $ | 1.05T $ |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 30.3 | 39.6 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 6.4 | 13.2 |
| Net marginShare of revenue retained as profit. | 21.5% | 33.5% |
| Return on equityReturn on equity (ROE). | 25.7% | 102.3% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +6.6% | +47.7% |
| Dividend yieldAnnual dividend relative to the share price. | 2.09% | 0.59% |
| Debt / equityFinancial debt relative to shareholders' equity. | 58% | 162% |
期间相关性
取值范围为−1至1：接近1时，两类资产同涨同跌；接近0时，二者走势相互独立。
- Johnson & Johnson / Eli Lilly0.45
对比分析
由人工智能生成的分析AI 仅根据上述数据比较所选资产，并指出哪些指标不可比。只有在您请求时才会生成文字内容。
以上信息仅供教育参考，不构成投资建议或个性化推荐。过往业绩不预示未来表现。